High Cholesterol (Hyperlipidemia) Clinical Trials

A listing of High Cholesterol (Hyperlipidemia) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

Acurian
Birmingham Alabama 35209

High Cholesterol Research Study

Acurian
Birmingham Alabama 35294

High Cholesterol Research Study

Acurian
Fort Payne Alabama 35967

High Cholesterol Research Study

Acurian
Gulf Shores Alabama 36542

High Cholesterol Research Study

Acurian
Hamilton Alabama 35570

High Cholesterol Research Study

Medical Affiliated Research Center, Inc.
Huntsville Alabama 35801

Help us explore a potential way to protect your heart

View More ▼

Alexander City Alabama 35010

Patients are needed to participate in a clinical research study of Bococizumab (PF-04950615; RN316) and Placebo to evaluate Hyperlipidemia or Mixed Dyslipidemia

Athens Alabama 35611

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Athens Alabama 35611

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Athens Alabama 35611

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Athens Alabama 35611

A Phase 3 clinical study for patients with Cardiovascular Disease

Athens Alabama 35611

A Phase 3 clinical study for patients with Cardiovascular Disease

Athens Alabama 35611

A Phase 3 clinical study for patients with Cardiovascular Disease

Auburn Alabama 36830

Patients are needed to participate in a clinical research study of Bococizumab (PF-04950615; RN316) and Placebo to evaluate Hyperlipidemia or Mixed Dyslipidemia

Birmingham Alabama 35216

A clinical research study of Bococizumab (PF-04950615;RN316) and Placebo for the treatment of Hyperlipidemia

Birmingham Alabama 35243

A clinical research study of Bococizumab (PF-04950615;RN316) and Placebo for the treatment of Hyperlipidemia

Birmingham Alabama 35243

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Birmingham Alabama 35294

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Birmingham Alabama 35209

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Birmingham Alabama 35209

A Phase 3 clinical study for patients with Cardiovascular Disease

Birmingham Alabama 35233

A Phase 3 clinical study for patients with Cardiovascular Disease

Birmingham Alabama 35294

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Payne Alabama 35967

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fort Payne Alabama 35967

A Phase 3 clinical study for patients with Cardiovascular Disease

Gulf Shores Alabama 36542

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Gulf Shores Alabama 36542

A Phase 3 clinical study for patients with Cardiovascular Disease

Huntsville Alabama 35801

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Huntsville Alabama 35801

A Phase 3 clinical study for patients with Cardiovascular Disease

Huntsville Alabama 35801

A Phase 3 clinical study for patients with Hyperlipidemia, High Cholesterol

Arizona

Acurian
Glendale Arizona 85308

High Cholesterol Research Study

Acurian
Sierra Vista Arizona 85635

High Cholesterol Research Study

Acurian
Tucson Arizona 85712

High Cholesterol Research Study

View More ▼

Chandler Arizona 85224

A Phase 3 clinical study for patients with Hyperlipidemia or Dyslipidemia

Glendale Arizona 85308

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Glendale Arizona 85308

A Phase 3 clinical study for patients with Cardiovascular Disease

Mesa Arizona 85213

A Phase 3 clinical study for patients with Hyperlipidemia, High Cholesterol

Phoenix Arizona 85020

A Phase 3 clinical study for patients with Hyperlipidemia, High Cholesterol

Phoenix Arizona 85018

Patients are needed to participate in a clinical research study of Bococizumab (PF-04950615; RN316) and Placebo to evaluate Hyperlipidemia or Mixed Dyslipidemia

Phoenix Arizona 85018

Patients are needed to participate in a clinical research study of Bococizumab (PF-04950615; RN316) and Placebo to evaluate Hyperlipidemia or Mixed Dyslipidemia

Sierra Vista Arizona 85635

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Sierra Vista Arizona 85635

A Phase 3 clinical study for patients with Cardiovascular Disease

Tempe Arizona 85282

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tempe Arizona 85282

A Phase 3 clinical study for patients with Cardiovascular Disease

Tucson Arizona 85710

A clinical research study of Bococizumab (PF-04950615;RN316) and Placebo for the treatment of Hyperlipidemia

Tucson Arizona 85710

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tucson Arizona 85710

A Phase 3 clinical study for patients with Cardiovascular Disease

Tucson Arizona 85712

Patients are needed to participate in a clinical research study of Bococizumab (PF-04950615; RN316) and Placebo to evaluate Hyperlipidemia or Mixed Dyslipidemia

Arkansas

Little Rock Arkansas 72202

A clinical study for patients using Ampicillin

Little Rock Arkansas 72204

Patient and Provider Assessment of Lipid Management Registry

Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study of Bococizumab (PF-04950615; RN316) and Placebo to evaluate Hyperlipidemia or Mixed Dyslipidemia